Tango Therapeutics, Inc.

Insider Reports History

Entity
Company
Location
201 Brookline Avenue, Suite 901, Boston, MA
Signature
/s/ Ariel Hurley, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tango Therapeutics, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 3.4K $306K $90.00 Dec 8, 2021 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 7K Dec 8, 2021 Direct

Insider Reports Filed by Tango Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Dec 8, 2021 2 $0 4 Dec 10, 2021 Director
BPMC Blueprint Medicines Corp Dec 8, 2021 0 $0 3 Dec 10, 2021 Director